SEC Form 4 · accession 0001209191-16-126370
Tracon Pharmaceuticals, Inc. · TCON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald L Shazer
Officer — Chief Medical Officer
Period of report
Jun 3, 2016
Accepted (ET)
Jun 7, 2016 · 7:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001394319
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 3, 2016 | S | 1,003 | $7.48 | D | 335 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2015.
- F2The Reporting Person acquired 1,338 shares under the 2015 Equity Incentive Plan on April 20, 2016.